AR and Familial prostate cancer: The finding of AR overexpression in GBM in the present study and based on the documented benefit of AR inhibitors in prostate cancer, the effect of AR inhibitors bicalutamide and enzalutamide on the survival of glioma cell lines A172, U87MG and T98G was explored.